{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T13:44:42Z","timestamp":1769348682480,"version":"3.49.0"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T00:00:00Z","timestamp":1721865600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004374","name":"Chongqing Medical University","doi-asserted-by":"publisher","award":["472020320230023"],"award-info":[{"award-number":["472020320230023"]}],"id":[{"id":"10.13039\/501100004374","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec><jats:title>Background &amp;amp; aims<\/jats:title><jats:p>HBV infection initiates autoimmune responses, leading to autoantibody generation. This research explores the role of autoantibodies in HBV-related Acute-on-Chronic Liver Failure (ACLF), offering novel perspectives for clinical management.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method<\/jats:title><jats:p>We applied immunoprecipitation and iTRAQ techniques to screen for autoantibodies in serum from HBV-related cirrhosis patients and conducted detection with conformation- stabilizing ELISA in a cohort of 238 HBV-infected individuals and 49 health controls. Our results were validated in a retrospective cohort comprising 106 ACLF patients and further assessed through immunohistochemical analysis in liver tissues from an additional 10 ACLF cases.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Utilizing iTRAQ, we identified Argonaute1-3 autoantibodies (AGO-Abs) in this research. AGO2-Abs notably increased in cirrhosis, decompensation, and further in ACLF, unlike AGO1-Abs and AGO3-Abs. This reflects disease severity correlation. Logistic regression and COX models confirmed AGO2-Abs as independent prognostic indicators for decompensated liver cirrhosis (DLC) and ACLF. In the ROC analysis, AGO2-Abs showed significant diagnostic value for predicting 28- and 90-day mortality (AUROC = 0.853 and 0.854, respectively). Furthermore, combining AGO2-Abs with the Child-Pugh, MELD, and AARC scores significantly improved their predictive accuracy (P &amp;lt; 0.05). Kaplan-Meier analysis showed poorer survival for AGO2-Abs levels above 99.14\u03bcg\/ml. These findings were supported by a retrospective validation cohort. Additionally, immunohistochemistry revealed band-like AGO2 expression in periportal liver areas, with AGO2-Abs levels correlating with total bilirubin, indicating a potential role in exacerbating liver damage through periportal functions.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>AGO2-Abs is a robust biomarker for predicting the mortality of patients with HBV-related ACLF.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcimb.2024.1407064","type":"journal-article","created":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T06:05:21Z","timestamp":1721887521000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Argonaute-2 autoantibodies: a promising biomarker for predicting mortality in HBV-related acute-on-chronic liver failure patients with cirrhosis"],"prefix":"10.3389","volume":"14","author":[{"given":"Yixuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huailu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zongqi","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaojing","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Long","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yixuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofeng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,7,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1053\/j.gastro.2013.04.005","article-title":"Underestimation of liver-related mortality in the United States","volume":"145","author":"Asrani","year":"2013","journal-title":"Gastroenterology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.jhep.2007.05.011","article-title":"The significance of autoantibodies and immunoglobulins in acute liver failure: a cohort study","volume":"47","author":"Bernal","year":"2007","journal-title":"J. Hepatol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/nature09092","article-title":"A dicer-independent miRNA biogenesis pathway that requires Ago catalysis","volume":"465","author":"Cheloufi","year":"2010","journal-title":"Nature"},{"key":"B4","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s12072-017-9816-z","article-title":"Liver failure determines the outcome in patients of acute-on-chronic liver failure (ACLF): comparison of APASL ACLF research consortium (AARC) and CLIF-SOFA models","volume":"11","author":"Choudhury","year":"2017","journal-title":"Hepatol. Int."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000001032","article-title":"Argonaute autoantibodies as biomarkers in autoimmune neurologic diseases","volume":"8","author":"Do","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"B6","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.ebiom.2015.04.007","article-title":"Serum DHCR24 auto-antibody as a new biomarker for progression of hepatitis C","volume":"2","author":"Ezzikouri","year":"2015","journal-title":"EBioMedicine"},{"key":"B7","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1074\/mcp.M113.035600","article-title":"Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics","volume":"13","author":"Fagerberg","year":"2014","journal-title":"Mol. Cell. proteomics: MCP"},{"key":"B8","doi-asserted-by":"publisher","first-page":"24213","DOI":"10.1073\/pnas.2008323117","article-title":"Extracellular microRNAs in human circulation are associated with miRISC complexes that are accessible to anti-AGO2 antibody and can bind target mimic oligonucleotides","volume":"117","author":"Geekiyanage","year":"2020","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1093\/brain\/awac276","article-title":"Distinct movement disorders in contactin-associated-protein-like-2 antibody-associated autoimmune encephalitis","volume":"146","author":"G\u00f6vert","year":"2023","journal-title":"Brain: J. Neurol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/gb-2008-9-2-210","article-title":"The Argonaute protein family","volume":"9","author":"H\u00f6ck","year":"2008","journal-title":"Genome Biol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41575-023-00760-9","article-title":"Global burden of hepatitis B virus: current status, missed opportunities and a call for action, Nature reviews","volume":"20","author":"Hsu","year":"2023","journal-title":"Gastroenterol. Hepatol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"R87","DOI":"10.1186\/ar1959","article-title":"Autoimmune targeting of key components of RNA interference","volume":"8","author":"Jakymiw","year":"2006","journal-title":"Arthritis Res. Ther."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118089","article-title":"The cooperative complex of Argonaute-2 and microRNA-146a regulates hepatitis B virus replication through flap endonuclease 1","volume":"257","author":"Ji","year":"2020","journal-title":"Life Sci."},{"key":"B14","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.molcel.2015.04.027","article-title":"Human argonaute 2 has diverse reaction pathways on target RNAs","volume":"59","author":"Jo","year":"2015","journal-title":"Mol. Cell"},{"key":"B15","doi-asserted-by":"publisher","first-page":"25487","DOI":"10.1038\/srep25487","article-title":"Characteristics, diagnosis and prognosis of acute-on-chronic liver failure in cirrhosis associated to hepatitis B","volume":"6","author":"Li","year":"2016","journal-title":"Sci. Rep."},{"key":"B16","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jhep.2015.01.029","article-title":"Submassive hepatic necrosis distinguishes HBV-associated acute on chronic liver failure from cirrhotic patients with acute decompensation","volume":"63","author":"Li","year":"2015","journal-title":"J. Hepatol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1002\/hep.32731","article-title":"Mitochondrial stress in advanced fibrosis and cirrhosis associated with chronic hepatitis B, chronic hepatitis C, or nonalcoholic steatohepatitis","volume":"77","author":"Loureiro","year":"2023","journal-title":"Hepatol. (Baltimore Md.)"},{"key":"B18","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1159\/000516412","article-title":"Elevation of autoantibodies to cerebral proteins in hepatic encephalopathy: another pathogenic factor","volume":"40","author":"Manzhalii","year":"2022","journal-title":"Digestive Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s12016-007-8013-6","article-title":"Hepatitis B virus (HBV) and autoimmune disease","volume":"34","author":"Maya","year":"2008","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.molcel.2004.07.007","article-title":"Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs","volume":"15","author":"Meister","year":"2004","journal-title":"Mol. Cell"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/j.jhep.2011.02.021","article-title":"The role of liver biopsy in the diagnosis and prognosis of patients with acute deterioration of alcoholic cirrhosis","volume":"55","author":"Mookerjee","year":"2011","journal-title":"J. Hepatol."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.972161","article-title":"Conformation-stabilizing ELISA and cell-based assays reveal patient subgroups targeting three different epitopes of AGO1 antibodies","volume":"13","author":"Moritz","year":"2022","journal-title":"Front. Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"6618","DOI":"10.1093\/nar\/gkac519","article-title":"Anatomy of four human Argonaute proteins","volume":"50","author":"Nakanishi","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jaut.2018.10.021","article-title":"Viral hepatitis, inflammation, and cancer: A lesson for autoimmunity","volume":"95","author":"Piconese","year":"2018","journal-title":"J. Autoimmun."},{"key":"B25","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nrgastro.2015.219","article-title":"Acute-on-chronic liver failure: terminology, mechanisms and management, Nature reviews","volume":"13","author":"Sarin","year":"2016","journal-title":"Gastroenterol. Hepatol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s12072-019-09946-3","article-title":"Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update","volume":"13","author":"Sarin","year":"2019","journal-title":"Hepatol. Int."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12072-015-9675-4","article-title":"Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update","volume":"10","author":"Sarin","year":"2016","journal-title":"Hepatol. Int."},{"key":"B28","first-page":"45","article-title":"Autoantibodies to argonaute 2 (Su antigen)","volume-title":"Adv Exp Med Biol.","author":"Satoh","year":"2013"},{"key":"B29","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1073\/pnas.1112263109","article-title":"Stabilization of hepatitis C virus RNA by an Ago2-miR-122 complex","volume":"109","author":"Shimakami","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B30","article-title":"Natural igG autoantibodies are abundant and ubiquitous in human sera, and their number is influenced by age, gender, and disease","volume":"8","author":"Tsokos","year":"2013","journal-title":"PloS One"},{"key":"B31","first-page":"842","article-title":"Autoantibodies to a miRNA-binding protein Argonaute2 (Su antigen) in patients with hepatitis C virus infection","volume":"28","author":"V\u00e1zquez-Del Mercado","year":"2010","journal-title":"Clin. Exp. Rheumatol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s00535-021-01788-x","article-title":"Evidence-based clinical practice guidelines for Liver Cirrhosis 2020","volume":"56","author":"Yoshiji","year":"2021","journal-title":"J. Gastroenterol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12964-023-01091-7","article-title":"Insights into the impact of hepatitis B virus on hepatic stellate cell activation","volume":"21","author":"You","year":"2023","journal-title":"Cell Commun. Signal.: CCS"},{"key":"B34","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13045-020-00918-x","article-title":"Autoantibody signature in hepatocellular carcinoma using seromics","volume":"13","author":"Zhang","year":"2020","journal-title":"J. Hematol. Oncol."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2024.1407064\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T06:05:29Z","timestamp":1721887529000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2024.1407064\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,25]]},"references-count":34,"alternative-id":["10.3389\/fcimb.2024.1407064"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2024.1407064","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,25]]},"article-number":"1407064"}}